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IranBackground: Schizophrenia is a common and severe neuropsychiatric disorder with symptoms such as
hallucination, delusion and mental disease. Among candidate genes for schizophrenia, miR-137 gene
has been recently suggested to contribute to schizophrenia by genome-wide association study (GWAS)
and a single nucleotide polymorphism (SNP) rs1625579 (G>T) as a presumed risk allele within an intron
of miR-137 gene has been contributed by schizophrenia. Since mir-137 is a considerable gene in the per-
formance of neural systems, the present study dealt with the association between SNP rs1625579 in miR-
137 gene and schizophrenia in Iranian patients.
Aim of study: This study aimed to evaluate the association between SNP rs1625579 in miR-137 gene and
schizophrenia in Iranian patients.
Methods: Hoping to identify a single-nucleotide polymorphism as a possible locus for schizophrenia, we
carried out this case-control study on 80 blood samples collected from individuals suffering from
schizophrenia and 48 healthy controls. DNA was extracted from the samples, and the frequency of the
polymorphisms was analyzed using ARMS-PCR method. Finally, the products were detected on 1.5% agar-
ose gel electrophoresis.
Results: The analysis on the data showed that 43.75% of the patients and 37.5% of the controls were
mutant homozygous and 56.25% of the patients and 62.5% of controls were heterozygous. In addition,
0.0% of the patients and 0.0% of the controls were normal homozygous. Both the genotype (p = .48 > .0
5) and allele (p = .5 > .05) distribution of the rs1625579 SNP has no significant difference between
patients and controls.
Conclusion: There was no significant relationship between rs1625579 and the incidence of schizophrenia.
To the best of our knowledge, this is first study in Iran that assesses the frequency of the polymorphism
among Iranian patients. However, further studies with more samples are necessary.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Schizophrenia is a common, complex and debilitating mental
disorder, which has significant morbidity, numerous heritability
and wide genetic heterogeneity [1]. Its incidence is about 1% of
the worldwide population [2]. The disorder is specified by positive
psychotic symptoms, including hallucinations, delusions and
disorganized behavior, and negative symptoms, such as socialwithdrawal and apathy [3]. It is due to multiple genes and environ-
mental factors and is a highly polygenic disease. However genetic
mechanisms are still unknown [2].
In the nervous system, miRNAs have cascaded influence on gene
expression and functional pathways by regulating many biological
processes such as embryonic and adult neurogenesis, axon guid-
ance, dendritic protein synthesis and synaptic development. There-
fore, they play a major role in a variety of diseases. The
dysregulation of miRNA expression leads to some abnormalities
in neural functions and structures [4,5] and causes psychiatric dis-
orders [6]. In 2011, Genome Wide Association Study (GWAS) has
provided evidence to suggest that MIR-137 is at the top of new
associations [7]. MIR-137 is located on chromosome 1p22 in
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cancer types [8]. Mir-137 is involved in multiple biological
processes is highly expressed in brain tissue and has a regulatory
role in both neurogenesis and synaptic plasticity and by recent
study, which has been confirmed as an association gene with
schizophrenia. According to Guan et al. and Egawa et al. there have
been many studies to confirm the association between many single
nucleotide polymorphism (SNP) loci of miR-137 (rs4634961,
rs9324387, rs2391905, rs4950117, rs1938568, rs4950101,
rs2802535, rs2660304, g.98511534 G>C, g.98511769 G>T, and
g.98511780 T>C) and schizophrenia not including the rs1625579
genotype. The location of rs1625579 was identified at an 8 kb
region downstream of host gene MIR137HG. This locus has a great
correlation with schizophrenia (p = 1.6  1011) in a large-scale
genome-wide association study (GWAS) of the disorder. There
have been some correlation studies on population; they demon-
strated that rs1625579 influence many phenotypes of schizophre-
nia (Table 1); Population consists of the UK, Australia, China, the
USA, and Canada. Lette et al. indicated that the time of beginning
of disease in patients who are with the TT genotype at this SNP
was so earlier than the patient who carried the G allele (p = 3.1
 105). Some research showed that white matter density in the
brain was diminished by the TT genotype. As a result of imaging
examinations, the TT genotype contributed to reduce hippocampal
volume and expanded lateral ventricles. These abnormalities may
be a consequence of the unusual development of neural growth
by dysregulation of miR-137 expression. Van Erp et al. signified
that TT genotype in rs1625579 was associated with poor working
memory, episodic memory and attention. The studies of Cummings
et al. on patients determined that the patients who have been with
T allele showed a few mental symptoms and more cognitive defi-
cits [9].
Despite these studies, we want to show whether this SNP asso-
ciates with schizophrenia in Iranian population or not. Therefore to
provide a more conclusive answer on rs1625579 as a risk of
schizophrenia in the present study, considering the importance
of this SNP using a simple rapid and cost-effective technique, we
made Tetra-Primer Amplification Refractory Mutation System
PCR (T-ARMS-PCR) for genotyping SNP rs1625579 of MIR137HG
gene. Using T-ARMS-PCR to confirm the association of the SNP
rs1625579 with schizophrenia, we conducted a case-control study
in a province of Iranian population. We considered the case-control
study involving 80 patients and 48 controls. The purpose of this
study was to evaluate the association between the rs1625579
and the clinical characteristics of schizophrenia as a diagnostic
biomarker.Table 1





American, Canadian (Lett et al.) 510 SZ 67.45 29.8
121 CTR 62.81 33.06 4.13
Australian (Green et al.) 491 SZ 64.97 31.16 3.87
328 CTR 62.5 33.23 4.27
Scottish (Whalley et al.) 44 SZ 59.09 38.64 2.27
81 CTR 61.73 35.8 2.47
American (Theo et al.) 48 SZ 81.25 18.75 0
63 CTR 73.02 23.81 3.17
Chinese (Guan et al.) 1430 SZ 77.7 20.8 1.5
1570 CTR 74 23.6 2.4
Abbreviations: SZ, schizophrenia cases; CTR, healthy controls; BA, Brodmann area; DLPF
* Statistical analyses compared TT with GT/GG genotypes.2. Subjects and methods
2.1. Case-control sample
In this case-control study, we represented our study sample,
which includes 80 schizophrenia patients and 48 unrelated healthy
controls from Golestan province of Iran. The diagnosis of
schizophrenia was affirmed by some experienced psychiatrists
for the patients. It used the structured clinical interview based
on the diagnostic and statical Manual of Mental Disorders IV
(DSM-IV-IR) and interview for negative and positive symptom
scale (PANSS) was carried out. Control subjects selected from the
same province and their hospitalization history for psychiatric dis-
orders was perused individually and they did not have any
unhealthy backgrounds. After obtaining informed consent from
patients, a dose of 5 ml blood was taken in an EDTA-containing
vial. The vials were transferred to the Milad Medical Genetic Labo-
ratory by maintaining the cold chain and kept at 4 C until the next
process.
2.2. DNA extraction
DNA was extracted from 800 mL of peripheral blood samples
leukocytes of case and control subjects by standard phenol-
chloroform method. First, lysis solution was used to lyse blood
cells. Then, DNA was precipitated by absolute ethanol. Last, it
was washed by 70% ethanol and dissolved in double distilled
water. After evaluating the purify, quality and concentration of
extracted DNA by spectrophotometer and electrophoresis in 0.8
agarose gel; DNA samples were stored at 20 C for genotype
analysis.
2.3. SNP genotyping
The genotype of SNP rs1625579 was determined using Tetra_
ARMS PCR. Four primers were designed using Primer3 software
(table 2.). Then, using Blast and Gene Runner software, we made
sure that they were proprietary and specific. To detect a specific
mutant, two primers were designed for T allele (mutant) and G
allele (normal). PCR was performed in a 25 mL reaction composed
of 12.5 mL of Amplicon (taq polymerase, dNTPs, Mgcl2, PCR buffer)
(cinnagen, Iran), 3 mL of template DNA, 1.4 mL of primers C, A and
1.4 mL of PCR primers. Amplification was performed with the fol-
lowing program:
5 min at 95 C, followed by 35 cycles of 95 C for 30 s, 63 C for
30 s, 72 C for 30 s and ending with a final extension step at 72 Cizophrenia and endophenotypes [9].
p-value Correlated phenotypes p-value
2.75 age-at-onset and white matter integrity 3.1  105*
>.05* 3.88  108*
.85* cognitive deficits in combination with greater .017*
>.05 activation in the posterior right medial
frontal gyrus, BA 6
<.001
.47* left DLPFC activation .02*
.023
C, Dorsal Lateral Prefrontal Cortex.
Table 2
The sequences of primers used to genotype SNP rs1625579 by Tetra-Primer ARMS PCR.
Name Primer Sequence PCR Production Length Allele Product
F common 50-GTGAATGTATCAACAGATTCCAAAGG-30 512 bp control fragment
FC 50-ACAAGGGAAATGTTAATCACAATTAC-30 351 bp C
FA 50-ACAAGGGAAATGTTAATCACAATTAA-30 351 bp Allele
R com order 50-AATAGCACAACAGAAGTGAACAGGG-30 512 bp A Allele control fragment
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two vials containing normal primers and mutant primers sepa-
rately and used a pair of primers as internal controls in the sam-
ples. In order to evaluate the accuracy of PCR productions and
genotyping, electrophoresis used in 1.5% agarose gel. PCR product
created in length of 512 bp was considered as a control fragment
for PCR reactions and a 351 bp fragment for the T allele and C allele
(Fig. 1). In order to confirm the accuracy of the method for deter-
mining the mutation and specifying definitively the type of muta-
tion; sequencing was performed (Fig. 2). The PCR productions wereFig. 1. The results of Tetra-Primers-ARMS PCR for genotyping of SNP rs1625579.
The 512 bp band represented the control fragment and the 351 bp fragment
amplification indicates the presence of T and G alleles at SNP site.
Fig. 2. The result of sequencing was consistent with determined genotype by T-ARMS-P













P < .05; df: degree of freedom; v2: Chi square.selected randomly then after sequencing the genotypes were com-
pared by PCR productions.3. Statistical analysis
Hardy-Weinberg equilibrium (HWE) examined using the Chi-
square test. Genotype and allele frequencies calculated in patients
and healthy controls. The odd ratio (OR) with 95% confidence inter-
vals (CI) calculated for the alleles and P-value  .05 considered sig-
nificant. Statistical analyzes performed using SPSS version 24.0
software.4. Result
For the association between rs1625579 polymorphism in miR-
137 and we analyzed data from 80 schizophrenia patients and 48
healthy controls. Tetra-primer ARMS-PCR was used for genotyping
the SNP rs1625579 in MIR137HG. After determining of the geno-
types of both groups, Hardy-Weinberg equilibrium was tested in
both the case and control populations. In both patients group
and controls group by Chi-square test, the allelic frequencies’ dis-
tributions were not in Hardy-Weinberg equilibrium what is its sig-
nificance for female (Table 3) the genotype frequencies in the
patients’ group were GG 0.0%; GT 56.25%; TT 43.75% vs. the geno-
type frequencies in the control group: GG 0.0%; GT 62.5%; TT 37.5%.
So the T allele was not significantly associated with schizophrenia
risk (p > .05) in Golestan province of Iran (Table 4). As the









Genotype and allele frequencies of the SNP rs1625579 in schizophrenic patients and controls.
N Genotype n (%) Allele n (%) OR 95% CI
TT GT + GG v2 P T G v2 P
Total
Patients 80 35 (43.75) 45 (56.25) 0.483 0.488 115 (71.87) 45 (28.12) 0.59 0.282 1.2963a 0.6231–2.6967
Controls 48 18 (37.5) 30 (62.5) 66 (68.75) 30 (31.25) 1.1616b 0.6687–2.0180
Male
Patients 70 31 (44.28) 39 (55.71) 0.412 0.52 101 (72.14) 39 (27.85) 0.244 0.62 1.3059a 0.5782–2.9495
Controls 37 14 (37.83) 23 (62.16) 51 (68.91) 23 (31.08) 1.1679b 0.6311–2.1614
Female
Patients 10 4 (40) 6 (60) 14 (70) 6 (30) 1.1667a 0.2000–6.8084
Controls 11 4 (36.36) 7 (63.63) 0.029 0.86 15 (68.18) 7 (31.81) 0.016 0.89 1.0889b 0.2934–4.0410
OR: odd ratio; 95% CI: 95% confidence interval.
a TT versus GT+GG.
b T versus G; P < .05.
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locus, which has not been associated with schizophrenia. Our anal-
yses showed that there was not a significant difference between
the TT genotype versus GT+GG genotypes in the case population
(v2 = 0.483, df = 1, p = .488) and the control population
(v2 = 0.412, df = 1, p = .5). Table 4 shows the summarized results
from statistical analyses.
5. Discussion
The latest GWAS in 2014 [2], the miR-137 gene was highly asso-
ciated with schizophrenia [10]. In this study, we investigated the
association of rs1625579 in Iran for the first time. Our study did
not confirm the association of SNP rs1625579 with schizophrenia
in the population of Iran. The major problem in genetic studies in
schizophrenia is that if one research confirmed a risk polymor-
phism in one population usually it cannot be approved in another
population [11]. The association of rs1625579 has been confirmed
in European populations as a risk SNP for schizophrenia. Previous
reports on SNP rs1625579 indicate that in Chinese the T allele
and TT genotype were risk factors and significant differences in
the genotype or allele distribution were identified between
patients and controls (v2 = 4.409, p = .036 and v2 = 4.971, p =
.026, respectively) [12]. These results demonstrated that
rs1625579 is a promising risk SNP under a recessive model, which
is the T allele. This data is in agreement with European GWAS
results [13–14]. In comparison with some studies, the frequency
of GG genotype in patients and controls was low (0.33% in the
cases and 0.80% in the controls) in Chinese Han’s population, and
a lower frequency of G allele was detected (5.16% in the cases
and 7.32% in the controls) in southern China. These results were
lower than the results in American and Canadian studies (17.65%
in the cases and 20.66% in the controls) which were observed
[15]. Much more significant differences of G allele and GG geno-
type frequencies between some Ethnicities were 20.37% and
2.47% in healthy Scottish controls [16] and 20.83% and 4.27% in
Australians [17] populations. Therefore, according to these data,
there was a risk of SNP rs1625579 for schizophrenia in European
populations and there were inconsistent results in Asian popula-
tions. These studies suggest that there is an ethnic heterogeneity
in distribution of SNP rs1625579 [12]. In our results, we failed to
find the association of miR-137 SNP with schizophrenia. Many rea-
sons must be involved for these results and maybe one of them is
that the participants of this study were from the Golestan province
of Iran. In many researches of Chinese’s population, data showed
that the T allele frequencies of SNP rs1625579 were different from
different geographical areas. Therefore, the small population must
be a limitation in this study, which may cause negative findings
[18].6. Conclusions
The results of our case-control study could not confirm the
association of MIR137HG rs1625579 with schizophrenia in this
sample size of Iranian populations. By this study, we try to exam-
ine the relationship between genetic variants of MIR137HG with
schizophrenia pathogenesis, and we hope this data will be helpful
on this way. Future studies in large-scale are needed to confirm the
exact association of MIR137HG gene with schizophrenia disease in
the Iranian population.
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